微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 55.76% | 16.38% | 1.36% | 64/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 55.01% | 18.04% | 9.73% | 67/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 50.13% | -4.88% | 2.76% | 71/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 48.78% | -18.61% | 1.82% | 78/129 | 53.83% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 47.91% | -25.21% | 2.81% | 79/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 46.6% | -29.24% | -11.57% | 79/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 52.7% | -22.35% | -12.07% | 70/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 59.93% | 8.64% | -6.44% | 53/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 64.06% | -4.91% | -2.73% | 44/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 65.86% | -7.75% | -2.95% | 40/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 67.87% | -4.76% | 23.02% | 35/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 55.17% | -32.93% | -18.11% | 77/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 67.37% | -20.41% | -5.64% | 38/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 71.4% | -17.3% | 0.2% | 33/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 71.25% | 2% | -13.37% | 29/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 82.25% | 32.05% | -2.83% | 13/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 84.65% | 2% | -1.95% | 8/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 86.33% | 2% | 38.61% | 5/129 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 62.29% | -0.97% | -0.97% | 55/129 | 56.37% | 正海生物 | 94.38% | 行业排名> |
| 2018-12-31 | 62.89% | -0.41% | -0.41% | 50/129 | 55.53% | 正海生物 | 93.12% | 行业排名> |
| 2017-12-31 | 63.15% | 6.65% | 6.65% | 43/129 | 55.34% | 正海生物 | 93.78% | 行业排名> |
| 2016-12-31 | 59.22% | 2% | 2% | 36/129 | 56.43% | 正海生物 | 93.09% | 行业排名> |